nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—PDE2A—rheumatoid arthritis	0.681	1	CbGaD
Dipyridamole—ABCC4—Methotrexate—rheumatoid arthritis	0.0123	0.248	CbGbCtD
Dipyridamole—ABCB1—Methylprednisolone—rheumatoid arthritis	0.00786	0.158	CbGbCtD
Dipyridamole—ABCB1—Betamethasone—rheumatoid arthritis	0.00511	0.103	CbGbCtD
Dipyridamole—ABCB1—Prednisolone—rheumatoid arthritis	0.00504	0.101	CbGbCtD
Dipyridamole—ABCB1—Hydrocortisone—rheumatoid arthritis	0.00478	0.0961	CbGbCtD
Dipyridamole—ABCB1—Prednisone—rheumatoid arthritis	0.00476	0.0957	CbGbCtD
Dipyridamole—ABCB1—Cyclosporine—rheumatoid arthritis	0.00452	0.0908	CbGbCtD
Dipyridamole—ABCB1—Dexamethasone—rheumatoid arthritis	0.00297	0.0598	CbGbCtD
Dipyridamole—ABCB1—Methotrexate—rheumatoid arthritis	0.00239	0.048	CbGbCtD
Dipyridamole—PDE6B—connective tissue—rheumatoid arthritis	0.00145	0.0931	CbGeAlD
Dipyridamole—PDE6B—lymphoid tissue—rheumatoid arthritis	0.00106	0.068	CbGeAlD
Dipyridamole—PRUNE—tendon—rheumatoid arthritis	0.00105	0.0673	CbGeAlD
Dipyridamole—PDE11A—tendon—rheumatoid arthritis	0.000928	0.0595	CbGeAlD
Dipyridamole—PDE7A—lymphoid tissue—rheumatoid arthritis	0.00088	0.0564	CbGeAlD
Dipyridamole—PDE3B—connective tissue—rheumatoid arthritis	0.000818	0.0524	CbGeAlD
Dipyridamole—PDE7B—tendon—rheumatoid arthritis	0.000723	0.0463	CbGeAlD
Dipyridamole—PDE10A—digestive system—rheumatoid arthritis	0.000634	0.0406	CbGeAlD
Dipyridamole—ADA—connective tissue—rheumatoid arthritis	0.00062	0.0397	CbGeAlD
Dipyridamole—PDE10A—tendon—rheumatoid arthritis	0.000604	0.0387	CbGeAlD
Dipyridamole—PDE2A—tendon—rheumatoid arthritis	0.000604	0.0387	CbGeAlD
Dipyridamole—PDE8A—tendon—rheumatoid arthritis	0.000518	0.0332	CbGeAlD
Dipyridamole—PDE5A—connective tissue—rheumatoid arthritis	0.000514	0.0329	CbGeAlD
Dipyridamole—PDE1A—tendon—rheumatoid arthritis	0.000501	0.0321	CbGeAlD
Dipyridamole—ADA—lymphoid tissue—rheumatoid arthritis	0.000453	0.029	CbGeAlD
Dipyridamole—ADA—digestive system—rheumatoid arthritis	0.000448	0.0287	CbGeAlD
Dipyridamole—SLC29A1—connective tissue—rheumatoid arthritis	0.000431	0.0276	CbGeAlD
Dipyridamole—ADA—tendon—rheumatoid arthritis	0.000426	0.0273	CbGeAlD
Dipyridamole—PDE5A—digestive system—rheumatoid arthritis	0.000371	0.0238	CbGeAlD
Dipyridamole—PDE5A—tendon—rheumatoid arthritis	0.000353	0.0226	CbGeAlD
Dipyridamole—PDE3A—tendon—rheumatoid arthritis	0.000344	0.022	CbGeAlD
Dipyridamole—ABCC5—tendon—rheumatoid arthritis	0.000323	0.0207	CbGeAlD
Dipyridamole—SLC29A1—lymphoid tissue—rheumatoid arthritis	0.000315	0.0202	CbGeAlD
Dipyridamole—SLC29A1—digestive system—rheumatoid arthritis	0.000312	0.02	CbGeAlD
Dipyridamole—SLC29A1—tendon—rheumatoid arthritis	0.000297	0.019	CbGeAlD
Dipyridamole—ABCC4—digestive system—rheumatoid arthritis	0.000235	0.0151	CbGeAlD
Dipyridamole—ABCC4—tendon—rheumatoid arthritis	0.000224	0.0143	CbGeAlD
Dipyridamole—Shock—Triamcinolone—rheumatoid arthritis	0.000107	0.00104	CcSEcCtD
Dipyridamole—Alopecia—Prednisone—rheumatoid arthritis	0.000107	0.00103	CcSEcCtD
Dipyridamole—Shock—Methylprednisolone—rheumatoid arthritis	0.000107	0.00103	CcSEcCtD
Dipyridamole—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	0.000106	0.00103	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	0.000106	0.00103	CcSEcCtD
Dipyridamole—Loss of consciousness—Dexamethasone—rheumatoid arthritis	0.000106	0.00103	CcSEcCtD
Dipyridamole—Loss of consciousness—Betamethasone—rheumatoid arthritis	0.000106	0.00103	CcSEcCtD
Dipyridamole—Paraesthesia—Prednisolone—rheumatoid arthritis	0.000106	0.00103	CcSEcCtD
Dipyridamole—Rash—Leflunomide—rheumatoid arthritis	0.000106	0.00103	CcSEcCtD
Dipyridamole—Tachycardia—Triamcinolone—rheumatoid arthritis	0.000106	0.00103	CcSEcCtD
Dipyridamole—Dermatitis—Leflunomide—rheumatoid arthritis	0.000106	0.00103	CcSEcCtD
Dipyridamole—Nausea—Azathioprine—rheumatoid arthritis	0.000106	0.00102	CcSEcCtD
Dipyridamole—Tachycardia—Methylprednisolone—rheumatoid arthritis	0.000106	0.00102	CcSEcCtD
Dipyridamole—Headache—Leflunomide—rheumatoid arthritis	0.000105	0.00102	CcSEcCtD
Dipyridamole—Skin disorder—Methylprednisolone—rheumatoid arthritis	0.000105	0.00102	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	0.000105	0.00102	CcSEcCtD
Dipyridamole—Hyperhidrosis—Triamcinolone—rheumatoid arthritis	0.000105	0.00102	CcSEcCtD
Dipyridamole—Hyperhidrosis—Methylprednisolone—rheumatoid arthritis	0.000105	0.00102	CcSEcCtD
Dipyridamole—Convulsion—Dexamethasone—rheumatoid arthritis	0.000105	0.00101	CcSEcCtD
Dipyridamole—Convulsion—Betamethasone—rheumatoid arthritis	0.000105	0.00101	CcSEcCtD
Dipyridamole—Hypertension—Dexamethasone—rheumatoid arthritis	0.000104	0.00101	CcSEcCtD
Dipyridamole—Hypertension—Betamethasone—rheumatoid arthritis	0.000104	0.00101	CcSEcCtD
Dipyridamole—Paraesthesia—Hydrocortisone—rheumatoid arthritis	0.000104	0.001	CcSEcCtD
Dipyridamole—Urticaria—Cyclosporine—rheumatoid arthritis	0.000103	0.000999	CcSEcCtD
Dipyridamole—Myalgia—Betamethasone—rheumatoid arthritis	0.000103	0.000996	CcSEcCtD
Dipyridamole—Myalgia—Dexamethasone—rheumatoid arthritis	0.000103	0.000996	CcSEcCtD
Dipyridamole—Abdominal pain—Cyclosporine—rheumatoid arthritis	0.000103	0.000994	CcSEcCtD
Dipyridamole—Anxiety—Betamethasone—rheumatoid arthritis	0.000102	0.000993	CcSEcCtD
Dipyridamole—Anxiety—Dexamethasone—rheumatoid arthritis	0.000102	0.000993	CcSEcCtD
Dipyridamole—Discomfort—Dexamethasone—rheumatoid arthritis	0.000102	0.000984	CcSEcCtD
Dipyridamole—Discomfort—Betamethasone—rheumatoid arthritis	0.000102	0.000984	CcSEcCtD
Dipyridamole—Dyspepsia—Hydrocortisone—rheumatoid arthritis	0.000101	0.000984	CcSEcCtD
Dipyridamole—Haemoglobin—Methotrexate—rheumatoid arthritis	0.000101	0.000983	CcSEcCtD
Dipyridamole—Hypotension—Methylprednisolone—rheumatoid arthritis	0.000101	0.000981	CcSEcCtD
Dipyridamole—Pain—Prednisolone—rheumatoid arthritis	0.000101	0.000979	CcSEcCtD
Dipyridamole—Haemorrhage—Methotrexate—rheumatoid arthritis	0.000101	0.000978	CcSEcCtD
Dipyridamole—Hepatitis—Methotrexate—rheumatoid arthritis	0.000101	0.000978	CcSEcCtD
Dipyridamole—Pharyngitis—Methotrexate—rheumatoid arthritis	0.0001	0.000971	CcSEcCtD
Dipyridamole—Nausea—Leflunomide—rheumatoid arthritis	9.98e-05	0.000968	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	9.95e-05	0.000965	CcSEcCtD
Dipyridamole—Fatigue—Hydrocortisone—rheumatoid arthritis	9.94e-05	0.000964	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	9.89e-05	0.000959	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	9.87e-05	0.000957	CcSEcCtD
Dipyridamole—Pain—Hydrocortisone—rheumatoid arthritis	9.86e-05	0.000956	CcSEcCtD
Dipyridamole—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	9.85e-05	0.000955	CcSEcCtD
Dipyridamole—Oedema—Betamethasone—rheumatoid arthritis	9.85e-05	0.000955	CcSEcCtD
Dipyridamole—Oedema—Dexamethasone—rheumatoid arthritis	9.85e-05	0.000955	CcSEcCtD
Dipyridamole—Anaphylactic shock—Betamethasone—rheumatoid arthritis	9.85e-05	0.000955	CcSEcCtD
Dipyridamole—Ill-defined disorder—Prednisone—rheumatoid arthritis	9.75e-05	0.000945	CcSEcCtD
Dipyridamole—Paraesthesia—Triamcinolone—rheumatoid arthritis	9.75e-05	0.000945	CcSEcCtD
Dipyridamole—Feeling abnormal—Prednisolone—rheumatoid arthritis	9.73e-05	0.000943	CcSEcCtD
Dipyridamole—Paraesthesia—Methylprednisolone—rheumatoid arthritis	9.72e-05	0.000943	CcSEcCtD
Dipyridamole—Anaemia—Prednisone—rheumatoid arthritis	9.71e-05	0.000942	CcSEcCtD
Dipyridamole—Shock—Betamethasone—rheumatoid arthritis	9.69e-05	0.00094	CcSEcCtD
Dipyridamole—Shock—Dexamethasone—rheumatoid arthritis	9.69e-05	0.00094	CcSEcCtD
Dipyridamole—Dyspnoea—Triamcinolone—rheumatoid arthritis	9.68e-05	0.000938	CcSEcCtD
Dipyridamole—Nervous system disorder—Betamethasone—rheumatoid arthritis	9.66e-05	0.000937	CcSEcCtD
Dipyridamole—Nervous system disorder—Dexamethasone—rheumatoid arthritis	9.66e-05	0.000937	CcSEcCtD
Dipyridamole—Thrombocytopenia—Betamethasone—rheumatoid arthritis	9.64e-05	0.000935	CcSEcCtD
Dipyridamole—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	9.64e-05	0.000935	CcSEcCtD
Dipyridamole—Tachycardia—Dexamethasone—rheumatoid arthritis	9.61e-05	0.000932	CcSEcCtD
Dipyridamole—Tachycardia—Betamethasone—rheumatoid arthritis	9.61e-05	0.000932	CcSEcCtD
Dipyridamole—Angioedema—Prednisone—rheumatoid arthritis	9.6e-05	0.000931	CcSEcCtD
Dipyridamole—Hypersensitivity—Cyclosporine—rheumatoid arthritis	9.56e-05	0.000927	CcSEcCtD
Dipyridamole—Dyspepsia—Triamcinolone—rheumatoid arthritis	9.55e-05	0.000926	CcSEcCtD
Dipyridamole—Dyspepsia—Methylprednisolone—rheumatoid arthritis	9.53e-05	0.000924	CcSEcCtD
Dipyridamole—Hyperhidrosis—Betamethasone—rheumatoid arthritis	9.52e-05	0.000923	CcSEcCtD
Dipyridamole—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	9.52e-05	0.000923	CcSEcCtD
Dipyridamole—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	9.5e-05	0.000921	CcSEcCtD
Dipyridamole—Malaise—Prednisone—rheumatoid arthritis	9.48e-05	0.000919	CcSEcCtD
Dipyridamole—Vertigo—Prednisone—rheumatoid arthritis	9.44e-05	0.000916	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	9.43e-05	0.000914	CcSEcCtD
Dipyridamole—Syncope—Prednisone—rheumatoid arthritis	9.42e-05	0.000914	CcSEcCtD
Dipyridamole—Tinnitus—Methotrexate—rheumatoid arthritis	9.41e-05	0.000912	CcSEcCtD
Dipyridamole—Urticaria—Prednisolone—rheumatoid arthritis	9.38e-05	0.000909	CcSEcCtD
Dipyridamole—Cardiac disorder—Methotrexate—rheumatoid arthritis	9.36e-05	0.000908	CcSEcCtD
Dipyridamole—Fatigue—Triamcinolone—rheumatoid arthritis	9.36e-05	0.000907	CcSEcCtD
Dipyridamole—Fatigue—Methylprednisolone—rheumatoid arthritis	9.34e-05	0.000905	CcSEcCtD
Dipyridamole—Asthenia—Cyclosporine—rheumatoid arthritis	9.31e-05	0.000902	CcSEcCtD
Dipyridamole—Pain—Triamcinolone—rheumatoid arthritis	9.28e-05	0.0009	CcSEcCtD
Dipyridamole—Loss of consciousness—Prednisone—rheumatoid arthritis	9.24e-05	0.000896	CcSEcCtD
Dipyridamole—Hypotension—Dexamethasone—rheumatoid arthritis	9.2e-05	0.000892	CcSEcCtD
Dipyridamole—Hypotension—Betamethasone—rheumatoid arthritis	9.2e-05	0.000892	CcSEcCtD
Dipyridamole—Pruritus—Cyclosporine—rheumatoid arthritis	9.18e-05	0.00089	CcSEcCtD
Dipyridamole—Urticaria—Hydrocortisone—rheumatoid arthritis	9.16e-05	0.000888	CcSEcCtD
Dipyridamole—Angiopathy—Methotrexate—rheumatoid arthritis	9.15e-05	0.000888	CcSEcCtD
Dipyridamole—Immune system disorder—Methotrexate—rheumatoid arthritis	9.11e-05	0.000884	CcSEcCtD
Dipyridamole—Abdominal pain—Hydrocortisone—rheumatoid arthritis	9.11e-05	0.000884	CcSEcCtD
Dipyridamole—Convulsion—Prednisone—rheumatoid arthritis	9.11e-05	0.000883	CcSEcCtD
Dipyridamole—Mediastinal disorder—Methotrexate—rheumatoid arthritis	9.09e-05	0.000882	CcSEcCtD
Dipyridamole—Hypertension—Prednisone—rheumatoid arthritis	9.07e-05	0.00088	CcSEcCtD
Dipyridamole—Chills—Methotrexate—rheumatoid arthritis	9.05e-05	0.000878	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	8.97e-05	0.00087	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	8.97e-05	0.00087	CcSEcCtD
Dipyridamole—Arthralgia—Prednisone—rheumatoid arthritis	8.95e-05	0.000868	CcSEcCtD
Dipyridamole—Myalgia—Prednisone—rheumatoid arthritis	8.95e-05	0.000868	CcSEcCtD
Dipyridamole—Feeling abnormal—Triamcinolone—rheumatoid arthritis	8.94e-05	0.000867	CcSEcCtD
Dipyridamole—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	8.92e-05	0.000865	CcSEcCtD
Dipyridamole—Anxiety—Prednisone—rheumatoid arthritis	8.92e-05	0.000865	CcSEcCtD
Dipyridamole—Alopecia—Methotrexate—rheumatoid arthritis	8.92e-05	0.000864	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	8.89e-05	0.000862	CcSEcCtD
Dipyridamole—Diarrhoea—Cyclosporine—rheumatoid arthritis	8.87e-05	0.000861	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	8.86e-05	0.000859	CcSEcCtD
Dipyridamole—Paraesthesia—Betamethasone—rheumatoid arthritis	8.84e-05	0.000857	CcSEcCtD
Dipyridamole—Paraesthesia—Dexamethasone—rheumatoid arthritis	8.84e-05	0.000857	CcSEcCtD
Dipyridamole—Discomfort—Prednisone—rheumatoid arthritis	8.84e-05	0.000857	CcSEcCtD
Dipyridamole—Hypersensitivity—Prednisolone—rheumatoid arthritis	8.7e-05	0.000843	CcSEcCtD
Dipyridamole—Dyspepsia—Dexamethasone—rheumatoid arthritis	8.67e-05	0.000841	CcSEcCtD
Dipyridamole—Dyspepsia—Betamethasone—rheumatoid arthritis	8.67e-05	0.000841	CcSEcCtD
Dipyridamole—Urticaria—Triamcinolone—rheumatoid arthritis	8.62e-05	0.000836	CcSEcCtD
Dipyridamole—Urticaria—Methylprednisolone—rheumatoid arthritis	8.6e-05	0.000834	CcSEcCtD
Dipyridamole—Dysgeusia—Methotrexate—rheumatoid arthritis	8.6e-05	0.000834	CcSEcCtD
Dipyridamole—Dizziness—Cyclosporine—rheumatoid arthritis	8.58e-05	0.000832	CcSEcCtD
Dipyridamole—Anaphylactic shock—Prednisone—rheumatoid arthritis	8.58e-05	0.000832	CcSEcCtD
Dipyridamole—Oedema—Prednisone—rheumatoid arthritis	8.58e-05	0.000832	CcSEcCtD
Dipyridamole—Abdominal pain—Methylprednisolone—rheumatoid arthritis	8.56e-05	0.00083	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	8.5e-05	0.000824	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	8.5e-05	0.000824	CcSEcCtD
Dipyridamole—Back pain—Methotrexate—rheumatoid arthritis	8.5e-05	0.000824	CcSEcCtD
Dipyridamole—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	8.49e-05	0.000823	CcSEcCtD
Dipyridamole—Fatigue—Betamethasone—rheumatoid arthritis	8.49e-05	0.000823	CcSEcCtD
Dipyridamole—Fatigue—Dexamethasone—rheumatoid arthritis	8.49e-05	0.000823	CcSEcCtD
Dipyridamole—Shock—Prednisone—rheumatoid arthritis	8.44e-05	0.000818	CcSEcCtD
Dipyridamole—Pain—Betamethasone—rheumatoid arthritis	8.42e-05	0.000817	CcSEcCtD
Dipyridamole—Pain—Dexamethasone—rheumatoid arthritis	8.42e-05	0.000817	CcSEcCtD
Dipyridamole—Nervous system disorder—Prednisone—rheumatoid arthritis	8.41e-05	0.000816	CcSEcCtD
Dipyridamole—Tachycardia—Prednisone—rheumatoid arthritis	8.37e-05	0.000812	CcSEcCtD
Dipyridamole—Skin disorder—Prednisone—rheumatoid arthritis	8.33e-05	0.000808	CcSEcCtD
Dipyridamole—Hyperhidrosis—Prednisone—rheumatoid arthritis	8.29e-05	0.000804	CcSEcCtD
Dipyridamole—ABCB1—lymphoid tissue—rheumatoid arthritis	8.29e-05	0.00531	CbGeAlD
Dipyridamole—Asthenia—Hydrocortisone—rheumatoid arthritis	8.27e-05	0.000802	CcSEcCtD
Dipyridamole—Vomiting—Cyclosporine—rheumatoid arthritis	8.25e-05	0.0008	CcSEcCtD
Dipyridamole—ABCB1—digestive system—rheumatoid arthritis	8.19e-05	0.00525	CbGeAlD
Dipyridamole—Rash—Cyclosporine—rheumatoid arthritis	8.18e-05	0.000793	CcSEcCtD
Dipyridamole—Dermatitis—Cyclosporine—rheumatoid arthritis	8.17e-05	0.000792	CcSEcCtD
Dipyridamole—Pruritus—Hydrocortisone—rheumatoid arthritis	8.16e-05	0.000791	CcSEcCtD
Dipyridamole—Ill-defined disorder—Methotrexate—rheumatoid arthritis	8.15e-05	0.00079	CcSEcCtD
Dipyridamole—Headache—Cyclosporine—rheumatoid arthritis	8.13e-05	0.000788	CcSEcCtD
Dipyridamole—Anaemia—Methotrexate—rheumatoid arthritis	8.12e-05	0.000787	CcSEcCtD
Dipyridamole—Feeling abnormal—Betamethasone—rheumatoid arthritis	8.12e-05	0.000787	CcSEcCtD
Dipyridamole—Feeling abnormal—Dexamethasone—rheumatoid arthritis	8.12e-05	0.000787	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	8.05e-05	0.000781	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	8.05e-05	0.000781	CcSEcCtD
Dipyridamole—Hypersensitivity—Triamcinolone—rheumatoid arthritis	8e-05	0.000775	CcSEcCtD
Dipyridamole—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	7.98e-05	0.000774	CcSEcCtD
Dipyridamole—Malaise—Methotrexate—rheumatoid arthritis	7.92e-05	0.000768	CcSEcCtD
Dipyridamole—Vertigo—Methotrexate—rheumatoid arthritis	7.89e-05	0.000765	CcSEcCtD
Dipyridamole—Diarrhoea—Hydrocortisone—rheumatoid arthritis	7.89e-05	0.000765	CcSEcCtD
Dipyridamole—Urticaria—Betamethasone—rheumatoid arthritis	7.82e-05	0.000759	CcSEcCtD
Dipyridamole—Urticaria—Dexamethasone—rheumatoid arthritis	7.82e-05	0.000759	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	7.81e-05	0.000758	CcSEcCtD
Dipyridamole—Dizziness—Prednisolone—rheumatoid arthritis	7.81e-05	0.000757	CcSEcCtD
Dipyridamole—Asthenia—Triamcinolone—rheumatoid arthritis	7.79e-05	0.000755	CcSEcCtD
Dipyridamole—Abdominal pain—Betamethasone—rheumatoid arthritis	7.79e-05	0.000755	CcSEcCtD
Dipyridamole—Abdominal pain—Dexamethasone—rheumatoid arthritis	7.79e-05	0.000755	CcSEcCtD
Dipyridamole—Asthenia—Methylprednisolone—rheumatoid arthritis	7.77e-05	0.000753	CcSEcCtD
Dipyridamole—Nausea—Cyclosporine—rheumatoid arthritis	7.7e-05	0.000747	CcSEcCtD
Dipyridamole—Paraesthesia—Prednisone—rheumatoid arthritis	7.7e-05	0.000747	CcSEcCtD
Dipyridamole—Pruritus—Triamcinolone—rheumatoid arthritis	7.68e-05	0.000745	CcSEcCtD
Dipyridamole—Cough—Methotrexate—rheumatoid arthritis	7.66e-05	0.000743	CcSEcCtD
Dipyridamole—Pruritus—Methylprednisolone—rheumatoid arthritis	7.66e-05	0.000743	CcSEcCtD
Dipyridamole—Dizziness—Hydrocortisone—rheumatoid arthritis	7.62e-05	0.000739	CcSEcCtD
Dipyridamole—Convulsion—Methotrexate—rheumatoid arthritis	7.61e-05	0.000738	CcSEcCtD
Dipyridamole—Dyspepsia—Prednisone—rheumatoid arthritis	7.55e-05	0.000732	CcSEcCtD
Dipyridamole—Arthralgia—Methotrexate—rheumatoid arthritis	7.48e-05	0.000725	CcSEcCtD
Dipyridamole—Chest pain—Methotrexate—rheumatoid arthritis	7.48e-05	0.000725	CcSEcCtD
Dipyridamole—Myalgia—Methotrexate—rheumatoid arthritis	7.48e-05	0.000725	CcSEcCtD
Dipyridamole—Rash—Prednisolone—rheumatoid arthritis	7.44e-05	0.000722	CcSEcCtD
Dipyridamole—Dermatitis—Prednisolone—rheumatoid arthritis	7.44e-05	0.000721	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	7.43e-05	0.00072	CcSEcCtD
Dipyridamole—Diarrhoea—Methylprednisolone—rheumatoid arthritis	7.41e-05	0.000718	CcSEcCtD
Dipyridamole—Fatigue—Prednisone—rheumatoid arthritis	7.39e-05	0.000717	CcSEcCtD
Dipyridamole—Headache—Prednisolone—rheumatoid arthritis	7.39e-05	0.000717	CcSEcCtD
Dipyridamole—Discomfort—Methotrexate—rheumatoid arthritis	7.39e-05	0.000716	CcSEcCtD
Dipyridamole—Vomiting—Hydrocortisone—rheumatoid arthritis	7.33e-05	0.000711	CcSEcCtD
Dipyridamole—Rash—Hydrocortisone—rheumatoid arthritis	7.27e-05	0.000705	CcSEcCtD
Dipyridamole—Dermatitis—Hydrocortisone—rheumatoid arthritis	7.26e-05	0.000704	CcSEcCtD
Dipyridamole—Headache—Hydrocortisone—rheumatoid arthritis	7.22e-05	0.0007	CcSEcCtD
Dipyridamole—Dizziness—Triamcinolone—rheumatoid arthritis	7.18e-05	0.000696	CcSEcCtD
Dipyridamole—Anaphylactic shock—Methotrexate—rheumatoid arthritis	7.17e-05	0.000695	CcSEcCtD
Dipyridamole—Dizziness—Methylprednisolone—rheumatoid arthritis	7.16e-05	0.000694	CcSEcCtD
Dipyridamole—Feeling abnormal—Prednisone—rheumatoid arthritis	7.07e-05	0.000685	CcSEcCtD
Dipyridamole—Asthenia—Betamethasone—rheumatoid arthritis	7.07e-05	0.000685	CcSEcCtD
Dipyridamole—Asthenia—Dexamethasone—rheumatoid arthritis	7.07e-05	0.000685	CcSEcCtD
Dipyridamole—Nervous system disorder—Methotrexate—rheumatoid arthritis	7.03e-05	0.000682	CcSEcCtD
Dipyridamole—Thrombocytopenia—Methotrexate—rheumatoid arthritis	7.02e-05	0.000681	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Prednisone—rheumatoid arthritis	7.01e-05	0.00068	CcSEcCtD
Dipyridamole—Nausea—Prednisolone—rheumatoid arthritis	7.01e-05	0.00068	CcSEcCtD
Dipyridamole—Pruritus—Dexamethasone—rheumatoid arthritis	6.97e-05	0.000676	CcSEcCtD
Dipyridamole—Pruritus—Betamethasone—rheumatoid arthritis	6.97e-05	0.000676	CcSEcCtD
Dipyridamole—Skin disorder—Methotrexate—rheumatoid arthritis	6.96e-05	0.000675	CcSEcCtD
Dipyridamole—Hyperhidrosis—Methotrexate—rheumatoid arthritis	6.93e-05	0.000672	CcSEcCtD
Dipyridamole—Vomiting—Triamcinolone—rheumatoid arthritis	6.9e-05	0.000669	CcSEcCtD
Dipyridamole—Vomiting—Methylprednisolone—rheumatoid arthritis	6.89e-05	0.000668	CcSEcCtD
Dipyridamole—Nausea—Hydrocortisone—rheumatoid arthritis	6.85e-05	0.000664	CcSEcCtD
Dipyridamole—Rash—Triamcinolone—rheumatoid arthritis	6.84e-05	0.000664	CcSEcCtD
Dipyridamole—Dermatitis—Triamcinolone—rheumatoid arthritis	6.84e-05	0.000663	CcSEcCtD
Dipyridamole—Rash—Methylprednisolone—rheumatoid arthritis	6.83e-05	0.000662	CcSEcCtD
Dipyridamole—Dermatitis—Methylprednisolone—rheumatoid arthritis	6.82e-05	0.000662	CcSEcCtD
Dipyridamole—Urticaria—Prednisone—rheumatoid arthritis	6.81e-05	0.000661	CcSEcCtD
Dipyridamole—Headache—Triamcinolone—rheumatoid arthritis	6.8e-05	0.000659	CcSEcCtD
Dipyridamole—Headache—Methylprednisolone—rheumatoid arthritis	6.78e-05	0.000658	CcSEcCtD
Dipyridamole—Abdominal pain—Prednisone—rheumatoid arthritis	6.78e-05	0.000657	CcSEcCtD
Dipyridamole—Diarrhoea—Dexamethasone—rheumatoid arthritis	6.74e-05	0.000653	CcSEcCtD
Dipyridamole—Diarrhoea—Betamethasone—rheumatoid arthritis	6.74e-05	0.000653	CcSEcCtD
Dipyridamole—Hypotension—Methotrexate—rheumatoid arthritis	6.7e-05	0.000649	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	6.53e-05	0.000633	CcSEcCtD
Dipyridamole—Dizziness—Dexamethasone—rheumatoid arthritis	6.51e-05	0.000631	CcSEcCtD
Dipyridamole—Dizziness—Betamethasone—rheumatoid arthritis	6.51e-05	0.000631	CcSEcCtD
Dipyridamole—Nausea—Triamcinolone—rheumatoid arthritis	6.45e-05	0.000625	CcSEcCtD
Dipyridamole—Paraesthesia—Methotrexate—rheumatoid arthritis	6.44e-05	0.000624	CcSEcCtD
Dipyridamole—Nausea—Methylprednisolone—rheumatoid arthritis	6.43e-05	0.000624	CcSEcCtD
Dipyridamole—Dyspnoea—Methotrexate—rheumatoid arthritis	6.39e-05	0.00062	CcSEcCtD
Dipyridamole—Somnolence—Methotrexate—rheumatoid arthritis	6.37e-05	0.000618	CcSEcCtD
Dipyridamole—Hypersensitivity—Prednisone—rheumatoid arthritis	6.32e-05	0.000613	CcSEcCtD
Dipyridamole—Dyspepsia—Methotrexate—rheumatoid arthritis	6.31e-05	0.000612	CcSEcCtD
Dipyridamole—Vomiting—Betamethasone—rheumatoid arthritis	6.26e-05	0.000607	CcSEcCtD
Dipyridamole—Vomiting—Dexamethasone—rheumatoid arthritis	6.26e-05	0.000607	CcSEcCtD
Dipyridamole—Rash—Dexamethasone—rheumatoid arthritis	6.21e-05	0.000602	CcSEcCtD
Dipyridamole—Rash—Betamethasone—rheumatoid arthritis	6.21e-05	0.000602	CcSEcCtD
Dipyridamole—Dermatitis—Betamethasone—rheumatoid arthritis	6.2e-05	0.000602	CcSEcCtD
Dipyridamole—Dermatitis—Dexamethasone—rheumatoid arthritis	6.2e-05	0.000602	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	6.19e-05	0.0006	CcSEcCtD
Dipyridamole—Fatigue—Methotrexate—rheumatoid arthritis	6.18e-05	0.000599	CcSEcCtD
Dipyridamole—Headache—Dexamethasone—rheumatoid arthritis	6.17e-05	0.000598	CcSEcCtD
Dipyridamole—Headache—Betamethasone—rheumatoid arthritis	6.17e-05	0.000598	CcSEcCtD
Dipyridamole—Asthenia—Prednisone—rheumatoid arthritis	6.15e-05	0.000597	CcSEcCtD
Dipyridamole—Pain—Methotrexate—rheumatoid arthritis	6.13e-05	0.000594	CcSEcCtD
Dipyridamole—Pruritus—Prednisone—rheumatoid arthritis	6.07e-05	0.000588	CcSEcCtD
Dipyridamole—Feeling abnormal—Methotrexate—rheumatoid arthritis	5.91e-05	0.000573	CcSEcCtD
Dipyridamole—Diarrhoea—Prednisone—rheumatoid arthritis	5.87e-05	0.000569	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	5.86e-05	0.000568	CcSEcCtD
Dipyridamole—Nausea—Dexamethasone—rheumatoid arthritis	5.85e-05	0.000567	CcSEcCtD
Dipyridamole—Nausea—Betamethasone—rheumatoid arthritis	5.85e-05	0.000567	CcSEcCtD
Dipyridamole—Urticaria—Methotrexate—rheumatoid arthritis	5.69e-05	0.000552	CcSEcCtD
Dipyridamole—Dizziness—Prednisone—rheumatoid arthritis	5.67e-05	0.00055	CcSEcCtD
Dipyridamole—Abdominal pain—Methotrexate—rheumatoid arthritis	5.67e-05	0.000549	CcSEcCtD
Dipyridamole—Vomiting—Prednisone—rheumatoid arthritis	5.45e-05	0.000529	CcSEcCtD
Dipyridamole—Rash—Prednisone—rheumatoid arthritis	5.41e-05	0.000524	CcSEcCtD
Dipyridamole—Dermatitis—Prednisone—rheumatoid arthritis	5.4e-05	0.000524	CcSEcCtD
Dipyridamole—Headache—Prednisone—rheumatoid arthritis	5.37e-05	0.000521	CcSEcCtD
Dipyridamole—Hypersensitivity—Methotrexate—rheumatoid arthritis	5.28e-05	0.000512	CcSEcCtD
Dipyridamole—Asthenia—Methotrexate—rheumatoid arthritis	5.14e-05	0.000499	CcSEcCtD
Dipyridamole—Nausea—Prednisone—rheumatoid arthritis	5.09e-05	0.000494	CcSEcCtD
Dipyridamole—Pruritus—Methotrexate—rheumatoid arthritis	5.07e-05	0.000492	CcSEcCtD
Dipyridamole—Diarrhoea—Methotrexate—rheumatoid arthritis	4.9e-05	0.000476	CcSEcCtD
Dipyridamole—Dizziness—Methotrexate—rheumatoid arthritis	4.74e-05	0.00046	CcSEcCtD
Dipyridamole—Vomiting—Methotrexate—rheumatoid arthritis	4.56e-05	0.000442	CcSEcCtD
Dipyridamole—Rash—Methotrexate—rheumatoid arthritis	4.52e-05	0.000438	CcSEcCtD
Dipyridamole—Dermatitis—Methotrexate—rheumatoid arthritis	4.52e-05	0.000438	CcSEcCtD
Dipyridamole—Headache—Methotrexate—rheumatoid arthritis	4.49e-05	0.000435	CcSEcCtD
Dipyridamole—Nausea—Methotrexate—rheumatoid arthritis	4.26e-05	0.000413	CcSEcCtD
Dipyridamole—PDE1A—Disease—IL6R—rheumatoid arthritis	7.39e-06	4.92e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—IL6R—rheumatoid arthritis	7.39e-06	4.92e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—CXCL8—rheumatoid arthritis	7.39e-06	4.92e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—IL2—rheumatoid arthritis	7.37e-06	4.9e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—IL6—rheumatoid arthritis	7.33e-06	4.88e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL6R—rheumatoid arthritis	7.33e-06	4.87e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL2RA—rheumatoid arthritis	7.32e-06	4.87e-05	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—IL2—rheumatoid arthritis	7.32e-06	4.87e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—MAPK8—rheumatoid arthritis	7.31e-06	4.87e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—MAPK8—rheumatoid arthritis	7.31e-06	4.87e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MMP3—rheumatoid arthritis	7.31e-06	4.86e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—TYK2—rheumatoid arthritis	7.3e-06	4.86e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—CD80—rheumatoid arthritis	7.3e-06	4.86e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—TYK2—rheumatoid arthritis	7.29e-06	4.85e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—SLC25A12—rheumatoid arthritis	7.29e-06	4.85e-05	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—TGFB1—rheumatoid arthritis	7.29e-06	4.85e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—IL2—rheumatoid arthritis	7.27e-06	4.84e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—VEGFA—rheumatoid arthritis	7.26e-06	4.83e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—IL2—rheumatoid arthritis	7.26e-06	4.83e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—C3—rheumatoid arthritis	7.26e-06	4.83e-05	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—TP53—rheumatoid arthritis	7.24e-06	4.82e-05	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—TP53—rheumatoid arthritis	7.24e-06	4.82e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CCR5—rheumatoid arthritis	7.22e-06	4.81e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—LEP—rheumatoid arthritis	7.22e-06	4.8e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL2RA—rheumatoid arthritis	7.12e-06	4.74e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GC—rheumatoid arthritis	7.09e-06	4.72e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PTGES—rheumatoid arthritis	7.09e-06	4.72e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—IL2—rheumatoid arthritis	7.08e-06	4.71e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—IL2—rheumatoid arthritis	7.07e-06	4.7e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—C3—rheumatoid arthritis	7.06e-06	4.7e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—IL6—rheumatoid arthritis	7.05e-06	4.69e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PTK2—rheumatoid arthritis	7.03e-06	4.68e-05	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—CXCL8—rheumatoid arthritis	7e-06	4.66e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—SPP1—rheumatoid arthritis	6.98e-06	4.65e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—MMP9—rheumatoid arthritis	6.97e-06	4.64e-05	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—PTGS2—rheumatoid arthritis	6.97e-06	4.64e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—CXCL8—rheumatoid arthritis	6.95e-06	4.63e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—NFKB1—rheumatoid arthritis	6.9e-06	4.59e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CCL5—rheumatoid arthritis	6.9e-06	4.59e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—MMP9—rheumatoid arthritis	6.88e-06	4.58e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IFNG—rheumatoid arthritis	6.83e-06	4.55e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—VEGFA—rheumatoid arthritis	6.82e-06	4.54e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—NFKB1—rheumatoid arthritis	6.81e-06	4.53e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—FN1—rheumatoid arthritis	6.81e-06	4.53e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—TP53—rheumatoid arthritis	6.8e-06	4.52e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CSF2—rheumatoid arthritis	6.79e-06	4.52e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CCR5—rheumatoid arthritis	6.79e-06	4.52e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—MAPK8—rheumatoid arthritis	6.78e-06	4.51e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL6ST—rheumatoid arthritis	6.78e-06	4.51e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—IL6R—rheumatoid arthritis	6.76e-06	4.5e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—LEP—rheumatoid arthritis	6.76e-06	4.5e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—VEGFA—rheumatoid arthritis	6.75e-06	4.49e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—VEGFA—rheumatoid arthritis	6.75e-06	4.49e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—TYK2—rheumatoid arthritis	6.74e-06	4.48e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—TYK2—rheumatoid arthritis	6.74e-06	4.48e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—MMP9—rheumatoid arthritis	6.7e-06	4.46e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—IL6—rheumatoid arthritis	6.7e-06	4.46e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL2RA—rheumatoid arthritis	6.69e-06	4.45e-05	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—IL2—rheumatoid arthritis	6.69e-06	4.45e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—MAPK8—rheumatoid arthritis	6.69e-06	4.45e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—TYK2—rheumatoid arthritis	6.67e-06	4.44e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—TGFB1—rheumatoid arthritis	6.67e-06	4.44e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—IL2—rheumatoid arthritis	6.64e-06	4.42e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—C3—rheumatoid arthritis	6.64e-06	4.42e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—NFKB1—rheumatoid arthritis	6.63e-06	4.41e-05	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—IL6—rheumatoid arthritis	6.63e-06	4.41e-05	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—IL6—rheumatoid arthritis	6.63e-06	4.41e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—NOS3—rheumatoid arthritis	6.61e-06	4.4e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—NOS3—rheumatoid arthritis	6.61e-06	4.4e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CD4—rheumatoid arthritis	6.6e-06	4.39e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PLB1—rheumatoid arthritis	6.59e-06	4.39e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—LEP—rheumatoid arthritis	6.57e-06	4.37e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CD80—rheumatoid arthritis	6.52e-06	4.34e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—MAPK8—rheumatoid arthritis	6.52e-06	4.34e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—rheumatoid arthritis	6.49e-06	4.32e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—SPP1—rheumatoid arthritis	6.39e-06	4.25e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—rheumatoid arthritis	6.38e-06	4.25e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—FN1—rheumatoid arthritis	6.37e-06	4.24e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—CXCL8—rheumatoid arthritis	6.36e-06	4.23e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—POMC—rheumatoid arthritis	6.35e-06	4.22e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL6ST—rheumatoid arthritis	6.35e-06	4.22e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—VEGFA—rheumatoid arthritis	6.26e-06	4.17e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—TGFB1—rheumatoid arthritis	6.26e-06	4.16e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IFNG—rheumatoid arthritis	6.25e-06	4.16e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CCR5—rheumatoid arthritis	6.21e-06	4.13e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—POMC—rheumatoid arthritis	6.2e-06	4.13e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—TGFB1—rheumatoid arthritis	6.2e-06	4.12e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—TGFB1—rheumatoid arthritis	6.2e-06	4.12e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—FN1—rheumatoid arthritis	6.2e-06	4.12e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—IL6—rheumatoid arthritis	6.18e-06	4.11e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—LEP—rheumatoid arthritis	6.18e-06	4.11e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—VEGFA—rheumatoid arthritis	6.18e-06	4.11e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL6ST—rheumatoid arthritis	6.17e-06	4.11e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—TYK2—rheumatoid arthritis	6.16e-06	4.1e-05	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—TP53—rheumatoid arthritis	6.16e-06	4.1e-05	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—TP53—rheumatoid arthritis	6.16e-06	4.1e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—IL6—rheumatoid arthritis	6.13e-06	4.08e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL2RA—rheumatoid arthritis	6.12e-06	4.07e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CD80—rheumatoid arthritis	6.11e-06	4.06e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—IL6—rheumatoid arthritis	6.1e-06	4.06e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL1B—rheumatoid arthritis	6.09e-06	4.05e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—CD4—rheumatoid arthritis	6.09e-06	4.05e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—CD4—rheumatoid arthritis	6.09e-06	4.05e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—IL2—rheumatoid arthritis	6.08e-06	4.04e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—C3—rheumatoid arthritis	6.07e-06	4.04e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL2—rheumatoid arthritis	6.07e-06	4.04e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CCL2—rheumatoid arthritis	6.07e-06	4.04e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL6R—rheumatoid arthritis	6.05e-06	4.02e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—NOS3—rheumatoid arthritis	6.05e-06	4.02e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—PTGS2—rheumatoid arthritis	6.05e-06	4.02e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—PTGS2—rheumatoid arthritis	6.05e-06	4.02e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CD4—rheumatoid arthritis	6.03e-06	4.02e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—VEGFA—rheumatoid arthritis	6.02e-06	4.01e-05	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—TP53—rheumatoid arthritis	6e-06	3.99e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CD80—rheumatoid arthritis	5.94e-06	3.95e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	5.89e-06	3.92e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—FN1—rheumatoid arthritis	5.83e-06	3.88e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—POMC—rheumatoid arthritis	5.8e-06	3.86e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL6ST—rheumatoid arthritis	5.8e-06	3.86e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—ALB—rheumatoid arthritis	5.79e-06	3.85e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—MED1—rheumatoid arthritis	5.78e-06	3.85e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TGFB1—rheumatoid arthritis	5.75e-06	3.82e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—NFKB1—rheumatoid arthritis	5.68e-06	3.78e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CCL2—rheumatoid arthritis	5.68e-06	3.78e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TGFB1—rheumatoid arthritis	5.67e-06	3.77e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL6R—rheumatoid arthritis	5.66e-06	3.77e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—LEP—rheumatoid arthritis	5.65e-06	3.76e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—POMC—rheumatoid arthritis	5.65e-06	3.76e-05	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—IL6—rheumatoid arthritis	5.64e-06	3.75e-05	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—IL6—rheumatoid arthritis	5.64e-06	3.75e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—IL6—rheumatoid arthritis	5.6e-06	3.73e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—MAPK8—rheumatoid arthritis	5.59e-06	3.72e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CD80—rheumatoid arthritis	5.59e-06	3.72e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL1B—rheumatoid arthritis	5.57e-06	3.71e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—CD4—rheumatoid arthritis	5.57e-06	3.71e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL2—rheumatoid arthritis	5.55e-06	3.69e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—NOS3—rheumatoid arthritis	5.54e-06	3.68e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—PTGS2—rheumatoid arthritis	5.53e-06	3.68e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CCL2—rheumatoid arthritis	5.52e-06	3.68e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TGFB1—rheumatoid arthritis	5.52e-06	3.68e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TYK2—rheumatoid arthritis	5.51e-06	3.67e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL6R—rheumatoid arthritis	5.51e-06	3.67e-05	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—IL6—rheumatoid arthritis	5.49e-06	3.66e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—TP53—rheumatoid arthritis	5.49e-06	3.65e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	5.41e-06	3.6e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—NOS3—rheumatoid arthritis	5.41e-06	3.6e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ACP5—rheumatoid arthritis	5.38e-06	3.58e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—B3GNT2—rheumatoid arthritis	5.38e-06	3.58e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—FN1—rheumatoid arthritis	5.33e-06	3.55e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL6ST—rheumatoid arthritis	5.31e-06	3.53e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—POMC—rheumatoid arthritis	5.31e-06	3.53e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—NFKB1—rheumatoid arthritis	5.2e-06	3.46e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CCL2—rheumatoid arthritis	5.19e-06	3.46e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL6R—rheumatoid arthritis	5.18e-06	3.45e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TYK2—rheumatoid arthritis	5.16e-06	3.43e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—TP53—rheumatoid arthritis	5.15e-06	3.43e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—MAPK8—rheumatoid arthritis	5.11e-06	3.4e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CD80—rheumatoid arthritis	5.11e-06	3.4e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—TP53—rheumatoid arthritis	5.1e-06	3.4e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—TP53—rheumatoid arthritis	5.1e-06	3.4e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PTGS2—rheumatoid arthritis	5.06e-06	3.37e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—NOS3—rheumatoid arthritis	5.06e-06	3.37e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	5.05e-06	3.36e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—IL6—rheumatoid arthritis	5.02e-06	3.34e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TYK2—rheumatoid arthritis	5.02e-06	3.34e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—NOS3—rheumatoid arthritis	4.92e-06	3.28e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—POMC—rheumatoid arthritis	4.86e-06	3.23e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—BGN—rheumatoid arthritis	4.84e-06	3.22e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CXCL8—rheumatoid arthritis	4.8e-06	3.19e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CCL2—rheumatoid arthritis	4.75e-06	3.16e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL6R—rheumatoid arthritis	4.74e-06	3.15e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TP53—rheumatoid arthritis	4.73e-06	3.15e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TYK2—rheumatoid arthritis	4.72e-06	3.14e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—IL6—rheumatoid arthritis	4.67e-06	3.11e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—IL6—rheumatoid arthritis	4.67e-06	3.11e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TP53—rheumatoid arthritis	4.67e-06	3.11e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—NOS3—rheumatoid arthritis	4.63e-06	3.08e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL2—rheumatoid arthritis	4.58e-06	3.05e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—IL6—rheumatoid arthritis	4.56e-06	3.03e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TP53—rheumatoid arthritis	4.55e-06	3.03e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CXCL8—rheumatoid arthritis	4.49e-06	2.99e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ALOX5—rheumatoid arthritis	4.45e-06	2.96e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	4.45e-06	2.96e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—TGFB1—rheumatoid arthritis	4.37e-06	2.91e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—TGFB1—rheumatoid arthritis	4.37e-06	2.91e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CXCL8—rheumatoid arthritis	4.37e-06	2.91e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MMP9—rheumatoid arthritis	4.34e-06	2.89e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—IL6—rheumatoid arthritis	4.33e-06	2.88e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TYK2—rheumatoid arthritis	4.31e-06	2.87e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—NFKB1—rheumatoid arthritis	4.29e-06	2.86e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL2—rheumatoid arthritis	4.29e-06	2.86e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—IL6—rheumatoid arthritis	4.27e-06	2.84e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—IL6—rheumatoid arthritis	4.27e-06	2.84e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—NOS3—rheumatoid arthritis	4.23e-06	2.82e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MAPK8—rheumatoid arthritis	4.22e-06	2.81e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL2—rheumatoid arthritis	4.17e-06	2.78e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—IL6—rheumatoid arthritis	4.16e-06	2.77e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—IL6—rheumatoid arthritis	4.15e-06	2.76e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CXCL8—rheumatoid arthritis	4.11e-06	2.73e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MMP9—rheumatoid arthritis	4.06e-06	2.7e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—NFKB1—rheumatoid arthritis	4.02e-06	2.67e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—TGFB1—rheumatoid arthritis	4e-06	2.66e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MMP9—rheumatoid arthritis	3.95e-06	2.63e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MAPK8—rheumatoid arthritis	3.95e-06	2.63e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL2—rheumatoid arthritis	3.92e-06	2.61e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—NFKB1—rheumatoid arthritis	3.91e-06	2.6e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—IL6—rheumatoid arthritis	3.9e-06	2.6e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—VEGFA—rheumatoid arthritis	3.89e-06	2.59e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MAPK8—rheumatoid arthritis	3.84e-06	2.56e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CXCL8—rheumatoid arthritis	3.76e-06	2.5e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MMP9—rheumatoid arthritis	3.71e-06	2.47e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—NFKB1—rheumatoid arthritis	3.67e-06	2.45e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—VEGFA—rheumatoid arthritis	3.65e-06	2.43e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ENO1—rheumatoid arthritis	3.63e-06	2.42e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MAPK8—rheumatoid arthritis	3.61e-06	2.4e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL2—rheumatoid arthritis	3.59e-06	2.39e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TGFB1—rheumatoid arthritis	3.57e-06	2.38e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—IL6—rheumatoid arthritis	3.57e-06	2.38e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL6—rheumatoid arthritis	3.57e-06	2.37e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—VEGFA—rheumatoid arthritis	3.55e-06	2.36e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MMP9—rheumatoid arthritis	3.4e-06	2.26e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	3.4e-06	2.26e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—NFKB1—rheumatoid arthritis	3.36e-06	2.24e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TGFB1—rheumatoid arthritis	3.35e-06	2.23e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—VEGFA—rheumatoid arthritis	3.34e-06	2.22e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MAPK8—rheumatoid arthritis	3.3e-06	2.2e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—IL6—rheumatoid arthritis	3.29e-06	2.19e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—IL6—rheumatoid arthritis	3.29e-06	2.19e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL6—rheumatoid arthritis	3.26e-06	2.17e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TGFB1—rheumatoid arthritis	3.26e-06	2.17e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TGFB1—rheumatoid arthritis	3.06e-06	2.04e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—VEGFA—rheumatoid arthritis	3.05e-06	2.03e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—IL6—rheumatoid arthritis	3.01e-06	2e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TP53—rheumatoid arthritis	2.94e-06	1.96e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TGFB1—rheumatoid arthritis	2.8e-06	1.86e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TP53—rheumatoid arthritis	2.76e-06	1.83e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL6—rheumatoid arthritis	2.69e-06	1.79e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TP53—rheumatoid arthritis	2.68e-06	1.78e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CAT—rheumatoid arthritis	2.61e-06	1.74e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL6—rheumatoid arthritis	2.52e-06	1.68e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TP53—rheumatoid arthritis	2.52e-06	1.68e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL6—rheumatoid arthritis	2.45e-06	1.63e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL6—rheumatoid arthritis	2.31e-06	1.53e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TP53—rheumatoid arthritis	2.3e-06	1.53e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—MTHFR—rheumatoid arthritis	2.18e-06	1.45e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL6—rheumatoid arthritis	2.11e-06	1.4e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—POMC—rheumatoid arthritis	1.74e-06	1.16e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ALB—rheumatoid arthritis	1.59e-06	1.06e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—NOS3—rheumatoid arthritis	1.52e-06	1.01e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PTGS2—rheumatoid arthritis	1.39e-06	9.26e-06	CbGpPWpGaD
